Main Street Financial Solutions LLC Trims Stock Position in Colgate-Palmolive (NYSE:CL)

Main Street Financial Solutions LLC trimmed its holdings in Colgate-Palmolive (NYSE:CLFree Report) by 4.4% in the 4th quarter, HoldingsChannel reports. The fund owned 5,922 shares of the company’s stock after selling 274 shares during the quarter. Main Street Financial Solutions LLC’s holdings in Colgate-Palmolive were worth $472,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CL. Vest Financial LLC increased its position in shares of Colgate-Palmolive by 25.1% during the 4th quarter. Vest Financial LLC now owns 370,071 shares of the company’s stock worth $29,498,000 after purchasing an additional 74,337 shares during the last quarter. Central Bank & Trust Co. lifted its holdings in shares of Colgate-Palmolive by 22.1% in the 4th quarter. Central Bank & Trust Co. now owns 1,383 shares of the company’s stock worth $110,000 after acquiring an additional 250 shares during the last quarter. Dynamic Advisor Solutions LLC boosted its position in shares of Colgate-Palmolive by 9.2% during the 4th quarter. Dynamic Advisor Solutions LLC now owns 10,808 shares of the company’s stock worth $864,000 after purchasing an additional 910 shares during the period. Sarasin & Partners LLP increased its holdings in Colgate-Palmolive by 1.2% in the 4th quarter. Sarasin & Partners LLP now owns 4,053,634 shares of the company’s stock valued at $323,115,000 after purchasing an additional 49,980 shares during the last quarter. Finally, Cornerstone Wealth Management LLC increased its holdings in Colgate-Palmolive by 2.5% in the 4th quarter. Cornerstone Wealth Management LLC now owns 7,170 shares of the company’s stock valued at $571,000 after purchasing an additional 172 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insider Buying and Selling

In related news, insider Jennifer Daniels sold 3,538 shares of the company’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $84.67, for a total value of $299,562.46. Following the completion of the sale, the insider now directly owns 59,698 shares of the company’s stock, valued at approximately $5,054,629.66. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In related news, insider Jennifer Daniels sold 3,538 shares of the company’s stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $84.67, for a total value of $299,562.46. Following the completion of the sale, the insider now owns 59,698 shares in the company, valued at approximately $5,054,629.66. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Noel R. Wallace sold 69,948 shares of the firm’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $84.22, for a total transaction of $5,891,020.56. Following the transaction, the chief executive officer now directly owns 286,881 shares in the company, valued at $24,161,117.82. The disclosure for this sale can be found here. Insiders have sold 89,209 shares of company stock worth $7,667,425 in the last ninety days. 0.34% of the stock is owned by corporate insiders.

Colgate-Palmolive Stock Down 0.4 %

NYSE CL traded down $0.40 during trading on Friday, reaching $94.13. 4,135,238 shares of the company’s stock were exchanged, compared to its average volume of 4,852,708. The company has a 50 day moving average price of $89.81 and a two-hundred day moving average price of $83.76. The stock has a market cap of $77.23 billion, a P/E ratio of 29.79, a price-to-earnings-growth ratio of 3.47 and a beta of 0.40. Colgate-Palmolive has a 1 year low of $67.62 and a 1 year high of $95.59. The company has a debt-to-equity ratio of 13.21, a quick ratio of 0.70 and a current ratio of 1.06.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its earnings results on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, topping the consensus estimate of $0.82 by $0.04. The firm had revenue of $5.07 billion during the quarter, compared to analysts’ expectations of $4.96 billion. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The firm’s revenue was up 6.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.73 earnings per share. On average, equities research analysts anticipate that Colgate-Palmolive will post 3.53 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, May 15th. Investors of record on Monday, April 22nd were given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.12%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date was Friday, April 19th. Colgate-Palmolive’s dividend payout ratio (DPR) is 63.29%.

Analyst Ratings Changes

Several research analysts have recently commented on the company. Raymond James upgraded Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price target for the company in a research report on Monday, January 29th. StockNews.com downgraded Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 20th. Barclays increased their price target on shares of Colgate-Palmolive from $84.00 to $85.00 and gave the stock an “equal weight” rating in a research report on Tuesday, April 30th. TheStreet upgraded shares of Colgate-Palmolive from a “c+” rating to a “b+” rating in a report on Friday, January 26th. Finally, Wells Fargo & Company increased their target price on shares of Colgate-Palmolive from $90.00 to $92.00 and gave the stock an “equal weight” rating in a report on Monday, April 29th. Three investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Colgate-Palmolive has a consensus rating of “Moderate Buy” and an average target price of $92.35.

Read Our Latest Stock Report on Colgate-Palmolive

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.